Articles

Crohn’s a very personal disease

My sister Nina has Crohn’s disease, and a severe form of it at that. She never complained much -- she even had a sense of humor about a disease that some people consider unfit for polite conversation.
Written byAmy Swinderman
| 3 min read

The Summer Solstice came and went while we were preparingthis issue, and beyond my office window, children frolicked under sprinklers intheir backyards and cheerfully rode their bikes across sun-dappled sidewalks.

Summer was always my favorite time of year as a kid, givingme a much-needed break from my honors-program studies to write, play andindulge my overly active imagination, with the exception of one worry-filledsummer around my 10th year—a time I found myself reflecting on thismonth after interviewing the folks at the Crohn's and Colitis Foundation ofCanada (CCFC) and Vertex Pharmaceuticals Inc. (see story, "Probing the bowelsof disease").

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.